1. Home
  2. DRD vs ARQT Comparison

DRD vs ARQT Comparison

Compare DRD & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$26.02

Market Cap

3.4B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$22.51

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
ARQT
Founded
1895
2016
Country
South Africa
United States
Employees
3410
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DRD
ARQT
Price
$26.02
$22.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$32.63
$34.00
AVG Volume (30 Days)
310.5K
1.2M
Earning Date
08-19-2026
05-05-2026
Dividend Yield
2.23%
N/A
EPS Growth
N/A
88.79
EPS
N/A
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$34.35
$34.46
Revenue Next Year
$24.62
$29.77
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
91.34
52 Week Low
$13.08
$11.86
52 Week High
$39.37
$31.77

Technical Indicators

Market Signals
Indicator
DRD
ARQT
Relative Strength Index (RSI) 27.93 37.45
Support Level $23.26 $22.56
Resistance Level $30.91 $27.26
Average True Range (ATR) 1.22 0.92
MACD -0.91 -0.13
Stochastic Oscillator 3.35 22.56

Price Performance

Historical Comparison
DRD
ARQT

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: